The DNBSEQ User Group Meeting will be held at the Westin Boston Seaport District (Marina Ballroom I) on Tuesday, October 14, one day prior to the ASHG meeting. Whether you are a current DNBSEQ user or exploring the technology, you are welcome to join. The meeting will feature insights from users and partners, as well as updates on new products. The full-day program includes four sessions: DNBSEQ technology with a focus on sequencing applications, Stereo-seq technology highlighting spatial transcriptomics, data analysis with our partners NVIDIA and Google, and an exclusive tour with a sneak peek at the newest sequencer at our Customer Excellence Center in Boston.
Agenda
8:30–9:00 am
Breakfast & Networking
Clinical WGS
DNBSEQ technology is a highly accurate, flexible, and cost-effective sequencing platform—ideal for high-throughput WGS and a variety of clinical and research applications. In this session, speakers will highlight the paradigm shift from targeted panels to WGS in precision medicine and share experiences applying DNBSEQ-T7 for NIPT and other clinical tests. You will also hear about the new DNBSEQ-T1+, with talks covering its speed, scalability, and applications in single-cell sequencing, RNA modification profiling, and performance with partner technologies.
9:00–9:20 am
Welcome & Company intro
9:20–9:40 am
The Future of Clinical Diagnostics: Whole Genome Sequencing at Scale with DNBSEQ-T7
Arjan Bormans, CSO, Gene by Gene
9:40–10:10 am
Rapid confirmation of NIPT results via amniotic and CVS testing using the DNBSEQ- T7
Peter Nagy, CMO, Praxis Genomics
10:10–10:30 am
High-quality and efficient WGS for clinical genetic testing with DNBSEQ-T7
Greice Krautz-Peterson, Director of Laboratory Operations, Variantyx
10:30–10:40 am
Break
10:40–10:55 am
An end-to-end solution for multiplexed RNA modification profiling with AlidaBio EpiPlex
Andrew Price, VP of R&D, Alida Bioscience
10:55–11:10 am
DNBSEQ-T1+: fast, flexible, and scalable sequencing from discovery to clinical application
Complete Genomics
11:10–11:25 am
Enhanced single-cell RNA-Seq via Bio-Rad ddSEQ™ and DNBSEQ-T1+ sequencing platform
Patricia Schnepp, FBS, Bio-Rad Laboratories
11:25–11:40 am
High-quality performance of Takara Bio’s Shasta single-cell and Embgenix PGT-A technologies on DNBSEQ-T1+
Andrew Farmer, CSO, Takara Bioscience
11:40–12:00 pm
Round Table Discussion
12:00–12:30 pm
Lunch
Spatial Transcriptomics
Stereo-seq technology has transformed spatial biology with its unique combination of true single-cell resolution, large capture area, and species-agnostic design. This session will feature diverse applications of Stereo-seq, including studies of the cancer microbiome, fruit fly behavior, and brain organoids.
12:30–12:50 pm
Stereo-seq: Redefining What’s Possible in Spatial Transcriptomics
Complete Genomics
12:50–1:20 pm
Looking into the anti-social brain: spatial genomic insights into mechanisms of fruit fly behavior
Corbin Jones, Professor, Faculty Director Bioinformatic and Analytic Research Collaborative, UNC Chapel Hill
1:20–1:50 pm
Local environmental heterogeneity: Advancing our understanding of the cancer microbiome
Andrew Bartko, Executive Director of the CMI, UCSD
1:50–2:20 pm
Multi-transcriptomics integration of human-viral interactions using brain organoids
Elaine Lim, Assistant Professor, UMass Chan Medical School
2:20–2:35 pm
TBD
2:35–2:50 am
Break
2:50–3:00 pm
Twice the unique reads for half the price using Stereo-seq OMNI with SEQuoia ribodepletion
Cissy Jiang, Sr. Product Manager, Bio-Rad Laboratories
3:00–3:30 pm
Round Table Discussion
Analysis
This session highlights how our partners, NVIDIA and Google, are advancing the data analysis ecosystem for DNBSEQ users—showcasing faster, more scalable pipelines and new capabilities tailored to our latest sequencers.
3:30–3:45 pm
Benchmarking NVIDIA Parabricks GPU-accelerated workflows on DNBSEQ-T1+ and T7
Gary Burnett, Technical Marketing Engineer, NVIDIA
3:45–4:00 pm
Google Deepvariant updated model for the new DNBSEQ-T1+ and beyond
Lucas Brambrink, Software engineer, Google
4:00–4:10 pm
Closing
Exclusive Tour:
Be the First to See Our New Sequencer
Join us at our Customer Excellence Center (CEC) near Boston for an exclusive tour and a first look at our upcoming new sequencer, delivering faster speed and higher throughput than any other commercially available high-throughput sequencer.
CEC